Just a moment...
Convert scanned orders, printed notices, PDFs and images into clean, searchable, editable text within seconds. Starting at 2 Credits/page
Try Now →Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the controversy concerning the validity of the impugned excise notifications and rules still required a final adjudication, or had become academic in view of subsequent statutory developments and admitted facts.
Analysis: The controversy was found to have become academic because, during the pendency of the appeals, the Central rules governing Ayurvedic, Siddha and Unani drugs were amended to prohibit manufacture and sale of preparations containing more than 12% alcohol, and the respondents admitted that they were no longer manufacturing products attracting the impugned notifications. The court also noted that the broader constitutional questions on legislative competence, occupied field, and the scope of excise control over medicinal preparations were pending authoritative determination before a Constitution Bench in another matter. In these circumstances, the court refrained from recording a final opinion on the merits of the constitutional challenge.
Conclusion: No final opinion was expressed on the substantive validity of the impugned rules and notification, and the controversy was treated as academic.
Final Conclusion: The appeals were brought to an end without a conclusive merits determination, while preserving a limited protection against prosecution for acts done during the period when the High Court decision remained operative.